Molecular Formula | C17H14F2N4O
|
Molar Mass | 328.32 |
Density | 1.32±0.1 g/cm3(Predicted) |
Boling Point | 377.8±42.0 °C(Predicted) |
Solubility | DMSO: soluble15mg/mL, clear |
Appearance | White powder |
Color | white to beige |
pKa | 12.54±0.70(Predicted) |
Storage Condition | Sealed in dry,Store in freezer, under -20°C |
Stability | Stable for 1 year from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20°C for up to 3 months. |
In vitro study | ML 297 is completely inactive for GIRK 2/3 . ML297 shows concentration-dependent efficacy in expressing GIRK1/2 cells and with an EC 50 of 162 nM. ML297 shows a complete inability to modulate the activity of HEK-293 cells expressing GIRK 2 alone and GIRKGIRK 2/3 . |
In vivo study | ML297 (60 mg/kg; i.p.) shows a highly significant ability to both prevent convulsions and prevent fatality of the PTZ treatment. Animal Model: 8-10 months old C57/BL6 male mice (approximately 30 g) Dosage: 60 mg/kg Administration: Intraperitoneal injection Result: Most of the animals neither convulsions nor death. |